(ICHN) iShares MSCI China USD - Ratings and Ratios
Chinese, Stocks, Large-Cap, Mid-Cap, Technology
Description: ICHN iShares MSCI China USD
The iShares MSCI China UCITS ETF USD Acc is an exchange-traded fund that tracks the Morningstar China TME NR USD Index, providing investors with exposure to the Chinese equity market. As an Irish-domiciled ETF, it is listed on European exchanges, offering a diversified portfolio of Chinese stocks.
By analyzing the funds underlying index, we can infer that it comprises a broad range of Chinese equities, potentially including large-cap, mid-cap, and small-cap stocks. The funds investment objective is to replicate the performance of the underlying index, thereby providing investors with a low-cost and efficient way to gain exposure to the Chinese equity market.
Using the available technical data, we can observe that the funds price has been trending upwards, with its 20-day simple moving average (SMA) at $5.42, slightly below the current price of $5.43. The 50-day SMA is at $5.27, and the 200-day SMA is at $4.92, indicating a longer-term uptrend. The average true range (ATR) is 0.08, representing a daily price volatility of 1.44%. Given the current price and the SMA trends, we can forecast that the funds price is likely to continue its upward trajectory, potentially reaching $5.83, the 52-week high, in the near term.
Combining the technical analysis with the fundamental data, we note that the funds assets under management (AUM) stand at $3.96 billion, indicating a significant investor base and liquidity. With a strong AUM and a favorable technical trend, we can forecast that the fund is likely to attract more investors, potentially driving the price higher. Our forecast suggests that, based on the current technical and fundamental trends, the funds price could reach $6.20 within the next 12 months, representing a potential upside of 14.2% from the current price.
Additional Sources for ICHN ETF
ICHN ETF Overview
Market Cap in USD | 3,963m |
Category | China Equity |
TER | 0.28% |
IPO / Inception | 2019-06-20 |
ICHN ETF Ratings
Growth Rating | 54.5 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | 17 |
Analysts | - |
Fair Price Momentum | 5.37 USD |
Fair Price DCF | - |
ICHN Dividends
Currently no dividends paidICHN Growth Ratios
Growth Correlation 3m | 84.6% |
Growth Correlation 12m | 81% |
Growth Correlation 5y | 88.9% |
CAGR 5y | 21.20% |
CAGR/Max DD 5y | 0.96 |
Sharpe Ratio 12m | 0.11 |
Alpha | 24.76 |
Beta | 0.540 |
Volatility | 23.20% |
Current Volume | 213.6k |
Average Volume 20d | 223.7k |
Stop Loss | 5.4 (-2.7%) |
As of July 09, 2025, the stock is trading at USD 5.55 with a total of 213,593 shares traded.
Over the past week, the price has changed by -0.16%, over one month by +0.63%, over three months by +18.52% and over the past year by +33.98%.
Partly, yes. Based on ValueRay´s Analyses, iShares MSCI China USD (SW:ICHN) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 54.45 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ICHN is around 5.37 USD . This means that ICHN is currently overvalued and has a potential downside of -3.24%.
iShares MSCI China USD has no consensus analysts rating.
According to our own proprietary Forecast Model, ICHN iShares MSCI China USD will be worth about 6.1 in July 2026. The stock is currently trading at 5.55. This means that the stock has a potential upside of +9.19%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 6.1 | 9.2% |